Genomic profile of MYCN non-amplified neuroblastoma and potential for immunotherapeutic strategies in neuroblastoma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1755-8794
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Genomic profile of MYCN non-amplified neuroblastoma and potential for immunotherapeutic strategies in neuroblastoma ; volume:13 ; number:1 ; day:10 ; month:11 ; year:2020 ; pages:1-11 ; date:12.2020
BMC medical genomics ; 13, Heft 1 (10.11.2020), 1-11, 12.2020
- Creator
-
Lee, Eunjin
Lee, Ji Won
Lee, Boram
Park, Kyunghee
Shim, Joonho
Yoo, Keon Hee
Koo, Hong Hoe
Sung, Ki Woong
Park, Woong-Yang
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12920-020-00819-5
- URN
-
urn:nbn:de:101:1-2020122121170837203865
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:24 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lee, Eunjin
- Lee, Ji Won
- Lee, Boram
- Park, Kyunghee
- Shim, Joonho
- Yoo, Keon Hee
- Koo, Hong Hoe
- Sung, Ki Woong
- Park, Woong-Yang
- SpringerLink (Online service)
Other Objects (12)
SMAD9-MYCN positive feedback loop represents a unique dependency for MYCN-amplified neuroblastoma
Aurora-A prevents transcription-replication conflicts in MYCN-amplified neuroblastoma
MTHFD1 regulates the NADPH redox homeostasis in MYCN-amplified neuroblastoma
Impact of extracellular matrix stiffness on genomic heterogeneity in MYCN-amplified neuroblastoma cell line
Inhibitors of ribosome biogenesis repress the growth of MYCN-amplified neuroblastoma
LRP8‐mediated selenocysteine uptake is a targetable vulnerability in MYCN‐amplified neuroblastoma
Age related gene DST represents an independent prognostic factor for MYCN non-amplified neuroblastoma
MYCN, proliferative heterogeneity and treatment response ¡n neuroblastoma
MYCN, proliferative heterogeneity and treatment response in neuroblastoma
Transcription factor activating protein 4 is synthetically lethal and a master regulator of MYCN-amplified neuroblastoma
Identification and validation of a novel five-gene signature in high-risk MYCN-not-amplified neuroblastoma
Inhibition of autophagy potentiates the efficacy of Gli inhibitor GANT-61 in MYCN-amplified neuroblastoma cells
SMAD9-MYCN positive feedback loop represents a unique dependency for MYCN-amplified neuroblastoma
Aurora-A prevents transcription-replication conflicts in MYCN-amplified neuroblastoma
MTHFD1 regulates the NADPH redox homeostasis in MYCN-amplified neuroblastoma
Impact of extracellular matrix stiffness on genomic heterogeneity in MYCN-amplified neuroblastoma cell line
Inhibitors of ribosome biogenesis repress the growth of MYCN-amplified neuroblastoma
LRP8‐mediated selenocysteine uptake is a targetable vulnerability in MYCN‐amplified neuroblastoma
Age related gene DST represents an independent prognostic factor for MYCN non-amplified neuroblastoma
MYCN, proliferative heterogeneity and treatment response ¡n neuroblastoma
MYCN, proliferative heterogeneity and treatment response in neuroblastoma
Transcription factor activating protein 4 is synthetically lethal and a master regulator of MYCN-amplified neuroblastoma
Identification and validation of a novel five-gene signature in high-risk MYCN-not-amplified neuroblastoma
Inhibition of autophagy potentiates the efficacy of Gli inhibitor GANT-61 in MYCN-amplified neuroblastoma cells
SMAD9-MYCN positive feedback loop represents a unique dependency for MYCN-amplified neuroblastoma
Aurora-A prevents transcription-replication conflicts in MYCN-amplified neuroblastoma
MTHFD1 regulates the NADPH redox homeostasis in MYCN-amplified neuroblastoma
Impact of extracellular matrix stiffness on genomic heterogeneity in MYCN-amplified neuroblastoma cell line
Inhibitors of ribosome biogenesis repress the growth of MYCN-amplified neuroblastoma
LRP8‐mediated selenocysteine uptake is a targetable vulnerability in MYCN‐amplified neuroblastoma
Age related gene DST represents an independent prognostic factor for MYCN non-amplified neuroblastoma
MYCN, proliferative heterogeneity and treatment response ¡n neuroblastoma
MYCN, proliferative heterogeneity and treatment response in neuroblastoma
Transcription factor activating protein 4 is synthetically lethal and a master regulator of MYCN-amplified neuroblastoma
Identification and validation of a novel five-gene signature in high-risk MYCN-not-amplified neuroblastoma